Scandinavia study finds HPV vaccine safe

By Kathryn Doyle NEW YORK (Reuters Health) – In a large study of nearly a million girls in Denmark and Sweden, the human papillomavirus vaccine was not linked to short- or long-term health problems. The HPV vaccine, given in three doses over a period of six months to boys and girls around age 12, protects against infection by a virus that can cause cervical cancer. “There were not really any concerns before our study and no new ones after,” Lisen Arnheim-Dahlström said. She led the study at the Karolinska Institutet in Stockholm. …
Sexual Health News Headlines – Yahoo! News